Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements
2004 · Leukemia · 51 citations
https://doi.org/10.1038/sj.leu.2403613
M
Marina Lanciotti
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
111
Papers
1.3K
Citations
22
h-index
43
i10-index
Marina Lanciotti is an academic researcher from Università Campus Bio-Medico. The author has contributed to research in topics: Blood disorders and treatments & Immunodeficiency and Autoimmune Disorders & Acute Lymphoblastic Leukemia research. The author has an h-index of 22, co-authored 95 publications.
ORCID: 0000-0003-4900-6908Papers by this author
worksSodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes
2025 · International Journal of Molecular Sciences · 4 citations
https://doi.org/10.3390/ijms26052103
Impaired Mitochondrial Function and Marrow Failure in Patients Carrying a Variant of the SRSF4 Gene
2024 · International Journal of Molecular Sciences · 0 citations
https://doi.org/10.3390/ijms25042083
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat